S.No | Title | Sponsor | Principal Investigator | Co-Investigators (Co-I) & Site Manager |
---|---|---|---|---|
1. | Clinical evaluation for the prophylactic role of traditional Siddha formulation Vishasura Kudineer enlisted in Advisory of Ministry of AYUSH for COVID-19. | Ministry of AYUSH, Government of India, New Delhi, India. | Dr. K. Prasanna Purna, Professor, Department of Respiratory Medicine. | Co-I’s; Dr. Sivakumar Vijayaraghavalu, Professor and Head, Narayana Translational Research and Incubation Center (NTRIC). Dr. R. Shailaja (Ayush Clinician), Siddhar Research Institute, Chennai, India. |
2. | An Academic Multicentre Open Label Single Arm Study to Record the Efficacy of Indomethacin among Confirmed COVID-19 patients with Mild and Moderate Symptoms. | IIT Madras, Chennai, Tamil Nadu (TN) India. | Dr. K. Prasanna Purna Professor, Department of Respiratory Medicine. | Co-I; Dr. Sivakumar Vijayaraghavalu, NTRIC. Project in collaboration with IIT Madras. |
3. | An Academic Retrospective Study to Record the Efficacy of Paracetamol along with other drugs, among Confirmed COVID-19 patients with Mild and Moderate Symptoms. | |||
4. | Randomized, Parallel Group, Phase III Study to Compare Safety and Efficacy of BFLUID with a Commercially Available Solution, NUTRIFLEX PERI, as a Control Product in Patients Undergoing Gastrectomy or Colectomy. | Otsuka Pharmaceutical India Pvt. Ltd.; Clinical Research Organization (CRO) – JSS Medical Research, Chennai, TN, India. | Dr. Thirunavukkarasu, Professor, Department of Surgical Gastroenterology. | Dr. Gurudutt P Varty, Resident, Department of Surgical Gastroenterology. Site Manager – Dr. Sivakumar Vijayaraghavalu, NTRIC. |
5. | An Open Label, Balanced, Randomized, Multicentre, Multi-dose, Two – Treatment, Parallel, Comparative Phase III Clinical Trial to Determine the Safety and Efficacy of Biapenem 300 mg Injections Manufactured by BDR Pharmaceuticals Internationls PVT. Ltd. India with I-NEM (Imipenem 500 mg +Cilastin 500 mg) injection manufactured by Glenmark Pharmaceuticals, Indian Human Adult, Patients with Various Complicated Infections. | BDR Pharmaceuticals Internationals Pvt. Ltd., Mumbai, Maharashtra India. CRO – Spinos Life Science and Research Pvt. Ltd., Coimbatore, TN, India. | Dr. Bhimasen Soren, Professor and Head, Department of General Medicine. | Site Manager – Dr. Sivakumar Vijayaraghavalu, NTRIC. |
6. | An Academic study to evaluate Laphre – A Vaginal Pessary for treatment of Bacterial Vaginosis. | Tenshi Lifecare, Pvt. Ltd., Bangalore, Karnataka, India. | Dr. Neha, Senior Resident, Dept. of Obstetrics & Gynecology. | Site Manager – Dr. Sivakumar Vijayaraghavalu, NTRIC. |
7. | A Prospective, Randomized, Active Controlled Clinical Study Evaluating the Safety and Hemostat Effectiveness of Absorbable Hemostat Powder of XXXXXXXXXXXX., in comparison with AristaTM AH (Absorbable Hemostat) of BD, Warwick, RI, 02886, U.S.A in Mild or Moderate Parenchymal or Soft Tissue Bleeding During General Surgery. | Lucktin (Hainan) Biotech Co., Ltd, Haikou City, Hainan, China. CRO – Scitus Pharma Services Private Limited, Chennai, TN, India. | Dr. Mahidhar Reddy, Professor, Department of General Surgery. | Dr. S V Eswaran, Resident, Department of General Surgery. Site manager – Dr. Sivakumar Vijayaraghavalu, NTRIC. |
8. | A multi-center, Randomized, Open Label, Comparative Efficacy and Safety Study of Acetazolomide Opthalmic Gel 0.65% with Acetazolamide Extended- Release Capsules 500 mg Preoperatively in Glaucoma Patients Undergoing Surgery. | Shilpa Medicare Limited, Raichur, Karnataka, India. CRO – JSS Medical Research, Chennai, TN, India. | Dr. C. Amruth Kumar, Associate Professor, Department of Opthalmology. | Co-PI – Dr. Ramya Deepthi, P, Assistant Professor, Department of Opthalmology. Site Manager – Dr. Sivakumar Vijayaraghavalu, NTRIC. |
Copyright © . Narayana Medical College & Hospital. All rights reserved.